18FDG PET/CT in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
pubmed:
27
3
2020
medline:
28
8
2020
entrez:
27
3
2020
Statut:
ppublish
Résumé
An 86-year-old woman was referred for a rare but aggressive subtype of primary cutaneous lymphoma of the right lower limb: diffuse large B-cell lymphoma leg type. Initial evaluation by whole-body F-FDG PET/CT showed intense hypermetabolic activity of multiple cutaneous and subcutaneous nodules of the distal third of the right leg. Follow-up evaluations by F-FDG PET/CT showed complete response after 4 and 8 cycles of appropriate rituximab combination with polychemotherapy. Although no specific recommendations are available, our case stresses the major role of F-FDG PET/CT for initial extension and treatment response evaluation in clinical practice of primary cutaneous diffuse large B-cell lymphoma leg type.
Identifiants
pubmed: 32209875
doi: 10.1097/RLU.0000000000002995
pii: 00003072-202005000-00019
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Rituximab
4F4X42SYQ6
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
403-404Références
Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768–3785.
Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133:1703–1714.
Wilcox RA. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management. Am J Hematol. 2018;93:1427–1430.
Grange F, Beylot-Barry M, Courville P, et al. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases. Arch Dermatol. 2007;143:1144–1150.
Athalye L, Nami N, Shitabata P. A rare case of primary cutaneous diffuse large B-cell lymphoma, leg type. Cutis. 2018;102:E31–E34.
Sokol L, Naghashpour M, Glass LF. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management. Cancer Control. 2012;19:236–244.
Pham-Ledard A, Prochazkova-Carlotti M, Andrique L, et al. Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell–like diffuse large B-cell lymphoma. Mod Pathol. 2014;27:402–411.
Pham-Ledard A, Beylot-Barry M, Barbe C, et al. High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type. JAMA Dermatol. 2014;150:1173–1179.
Grange F, Joly P, Barbe C, et al. Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France. JAMA Dermatol. 2014;150:535–541.
Grange F, D'Incan M, Ortonne N, et al. Management of cutaneous B-cell lymphoma: recommendations of the French cutaneous lymphoma study group. Ann Dermatol Venereol. 2010;137:523–531.
Qiu L, Tu G, Li J, et al. The role of 18F-FDG PET and PET/CT in the evaluation of primary cutaneous lymphoma. Nucl Med Commun. 2017;38:106–116.
Spaccarelli N, Gharavi M, Saboury B, et al. Role of (18)F-fluorodeoxyglucose positron emission tomography imaging in the management of primary cutaneous lymphomas. Hell J Nucl Med. 2014;17:78–84.
Samarghandi A, Gru AA, Natwa M, et al. (18)FDG PET/CT appearance in primary cutaneous diffuse large B-cell lymphoma, leg type. Clin Nucl Med. 2015;40:506–508.
Ni C, Lewis M, Berenji G. FDG PET/CT findings in primary diffuse large B-cell lymphoma, leg type. Clin Nucl Med. 2016;41:65–68.